X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-09-25 | DMRA | Damora Therapeutics, Inc. | Jarrett Jennifer | Dir, Pres, CEO | P - Purchase | $20.23 | +12,500 | 512,500 | +3% | +$252,875 | ||||||
2026-09-25 | FTHY | First Trust High Yield Opportunities 2027 Term Fund | McGarel David | Officer-Investment Adviser | P - Purchase | $12.92 | +10,000 | 24,000 | +71% | +$129,247 | ||||||
2026-09-25 | DX | Dynex Capital Inc | Connelly Terrence John Jr | Chief Investment Officer | P - Purchase | $11.18 | +2,500 | 58,695 | +4% | +$27,950 | ||||||
2026-09-24 | ANIX | Anixa Biosciences Inc | Kumar Amit | CEO | P - Purchase | $2.78 | +7,000 | 672,000 | +1% | +$19,460 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |